Two Methods of Diagnosing Preterm Labor
Study Details
Study Description
Brief Summary
Use of modern diagnostic tools e.g. fetal fibronectin and ultrasound measurement of cervical length to diagnose preterm labor can result in improved outcomes compared to traditional diagnosis based on digital examination to measure cervical change.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Symptomatic preterm labor patients will be randomized to diagnosis of preterm labor by serial digital examination versus an algorithm incorporating transvaginal ultrasound measurement of cervical length and vaginal fetal fibronectin.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: PLAT Diagnosis of preterm labor will be made by the March of Dimes Preterm Labor Assessment Toolkit Algorithm B, incorporating transvaginal ultrasound measurement of cervical length, and vaginal fetal fibronectin |
Procedure: Diagnosis by cervical length and fibronectin
Diagnosis will be made by MOD Algorithm B
Other Names:
|
Placebo Comparator: Cervical Change Diagnosis of preterm labor will be made by cervical change by digital examination |
Procedure: Cervical change
Diagnosis will be made by digital examination of cervical change
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Delivery prior to 37 weeks' gestation [No longer than 18 weeks post randomization (at which time a pregnancy randomized at the earliest possible gestational age would be 42 weeks, generally the contemporary upper limit of the duration of pregnancy)]
Delivery of the baby prior to 37 weeks' gestation by any means and for any reason including spontaneous or indicated delivery for maternal or fetal complications
Eligibility Criteria
Criteria
Inclusion Criteria:
-
symptomatic complaints suggestive of preterm labor
-
greater than 6 contractions per hour
Exclusion Criteria:
-
multiple gestation
-
rupture of amniotic membranes
-
chorioamnionitis
-
congenital malformations
-
persistent vaginal bleeding
-
abruptio placentae
-
placenta previa
-
previously diagnosed short cervix < 2.5 cm
-
cervical dilation > 3 cm
-
cervical cerclage
-
exposure to tocolytic drugs
-
allergy or contraindication to nifedipine
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Community Regional Medical Center | Fresno | California | United States | 93701 |
Sponsors and Collaborators
- University of California, San Francisco
Investigators
- Principal Investigator: Conrad R Chao, MD, University of California, San Francisco
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2010010